GKB Ophthalmics Share Price

GKB Ophthalmics

CMP as on 29-Jan-15 0:00

₹ 84.05
-4.35 -4.92%

Open

₹ 84.50

Turnover (lac)

₹ 70

Prev. Close

₹ 88.40

Day's Vol (shares)

₹ 83,081

Day's Range (₹)

₹ 84.00
₹ 90.90

CMP as on16-May-22 15:29

₹ 81.75
6.8 9.07%

Open

₹ 76.45

Turnover (lac)

₹ 2

Prev. Close

₹ 74.95

Day's Vol (shares)

₹ 1,232

Day's Range

₹ 74.80
₹ 81.85

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 12-Mar-2022 - -
Pursuant to Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a separate Board Meeting of the Independent Directors of the Company is scheduled to be held on Thursday, March 17, 2022 at 10.30 A.M at the Registered office of the Company situated at Plot No. 16-A , Tivim Industrial Estate, Mapusa, Goa , 403 526, to consider the following business: 1. To review the performance of Non-Independent Directors and the Board as a whole; 2. To review the performance of the Chairperson of the Company, taking into account the views of Executive Directors and Non-Executive Directors; 3. To assess the quality, quantity and timeliness of flow of information between the Company management and the Board that is necessary for the Board to effectively and reasonably perform their duties; 4. Any other business with the permission of chair. A separate meeting of the Independent Directors of the Company for the year 2021-22, was held, pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and section 149(8) of the Companies Act, 2013, read with Schedule IV (VII). Since all the Independent Directors were present, no leave of absence was granted. The Independent Directors in their Meeting held today: 1.Reviewed the performance of Non-Independent Directors and the Board as a whole. 2.Reviewed the performance of the Chairperson of the Company, taking into account the views of the Executive Director and Non-Executive Directors. 3.Assessed the quality, quantity and timeliness of the flow of information between the Companys management and the Board. The Independent Directors Meeting started at 10:30 A.M. and ended at 11:15 A.M., on the same day. Kindly take note of the same. (As Per BSE Announcement Dated on 17.03.2022)
Board Meeting - 07-Mar-2022 - -
This is to inform that the meeting of the Board of Directors of the Company was held on March 07, 2022, in which the Board of Directors considered and approved: 1. Revised Policy on Related Party Transactions. 2. a) Related Party Transactions and b) Material Related Party Transactions, subject to the approval of shareholders. 3. Draft Postal Ballot Notice to seek consent of the Shareholders of the Company, for Material Related Party Transactions. This is for your kind information.
Board Meeting - 29-Jan-2022 - -
GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2021. Vide our letter dated December 31 2021 notice was given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) (Amendment) Regulations 2018 shall be closed from Saturday January 01 2022 till the completion of 48 hours after the declaration of the said financial results of the Company. The Trading Window shall now re-open on Tuesday February 15 2022. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on February 12, 2022, which considered and took on record, the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2021. Pursuant to Regulation 33(3) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone financial results for the quarter and nine months ended December 31, 2021, together with the Limited Review Report. . 2. Consolidated financial results for the quarter and nine months ended December 31, 2021, together with the Limited Review Report. The above Unaudited standalone and consolidated financial results and the limited review reports are available on the Companys website www.gkb.net and the BSE website www.bseindia.com (As Per BSE Announcement Dated on 12.02.2022)
Board Meeting - 29-Oct-2021 - -
Quarterly Results The meeting of the Board of Directors of the Company was held on November 11, 2021, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and half year ended September 30, 2021, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and half year ended September 30, 2021, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Companys website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors Meeting started at 4:30 P.M. and ended at 5:50 P.M., on the same day. Kindly take the information on record. (As Per BSE Announcement Dated 11.11.2021)
Board Meeting - 05-Aug-2021 - -
Quarterly Results Further to our letter dated August 11, 2021, we wish to inform you that the Board of Directors at its meeting held on August 13, 2021, has considered and approved the requests received from Mr. Krishna Murari Gupta , Mrs. Usha Gupta, Mr. Aditya Gupta and Mr. Vivek Gupta ( K.M. Gupta & Family) for reclassification of their shareholding from the Promoter and Promoter Group category to the Public category of shareholders of the Company, in accordance with Regulation 31A, of Listing Regulations. The meeting of the Board of Directors of the Company was held on August 13, 2021, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2021. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter ended June 30, 2021, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter ended June 30, 2021, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Companys website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors Meeting started at 04:45 P.M. and ended at 05:30 P.M., on the same day. Kindly take the information on record. (As per BSE Announcement Dated on 13/8/2021) This approval of Board of Directors is subject to the approval of members , Securities and Exchange Board of India, Stock Exchange and other appropriate authorities, as may be necessary. Pursuant to the provisions of Regulation 31A, please find enclosed certified extract of the minutes of the Board of Directors. Kindly take the information on record. (As Per BSE Announcement Dated 14.08.2021)
Board Meeting - 31-May-2021 - -
GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2021 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2021. The Notice can be accessed at the Companys website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors, that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, had been closed from April 01, 2021, will now re-open on Monday, June 14, 2021. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on June 10, 2021, which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2021. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and year ended March 31, 2021, together with Auditors Report . 2. Consolidated Financial Results for the quarter and year ended March 31, 2021, along with Auditors Report. 3. A declaration from CFO with respect to Audit Report with unmodified opinion for the financial year ended March 31, 2021, in terms of SEBI Circular no. CIR/ CFD/CMD/56/2016 dated May 27, 2016. The above Audited Financial Results and Auditors Reports are available on the Companys website www.gkb.net and on the BSE website www.bseindia.com GKB Ophthalmics Ltd has informed BSE about Outcome of Board Meeting held on June 10, 2021. (As Per BSE Announcement dated on 10.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity